関連する実験動画
Updated: Jul 16, 2026

08:32
Extraction of Tissue Antigens for Functional Assays
Published on: September 10, 2012
免疫学: 1型糖尿病におけるインスリン自身抗原性
1Torrey Pines Institute for Molecular Studies, San Diego, California 92121-1122, USA. dbwilson@tpims.org
Nature
|November 25, 2005
まとめ
インスリンは,T細胞の反応を誘発することで,自己免疫性1型糖尿病を誘発する可能性があります. しかし,インスリン断片に対する非典型のT細胞反応は,この自己免疫糖尿病仮説に異議を唱え,予防と治療戦略に影響を与えます.
科学分野:
- 免疫学 免疫学とは
- エンドクリノロジー エンドクリノロジー
- 自己免疫疾患 自己免疫疾患
背景:
- 1型糖尿病は,胰腺ベータ島細胞の自己免疫破壊により発生し,インスリン欠乏症と高血糖症を引き起こします.
- 甲状腺由来リンパ球 (T細胞) は1型糖尿病の病原化に関与しているが,自己抗原を誘発する原因は十分に理解されていない.
研究 の 目的:
- マウスとヒトにおける自発的な1型糖尿病を誘発する主要な自己抗原としてのインスリンを調査する.
- 1型糖尿病の予防と治療における自己抗原として作用するインスリンの影響を評価する.
主な方法:
- 自己免疫糖尿病の文脈におけるインスリンとその断片に対するT細胞反応の分析.
- マウスモデルでの発見の比較研究 (Nakayama et al.) とヒトに関する研究 (Kent et al. ) を実施する.
主要な成果:
- ナカヤマ et al. ほか そして,ケント et al. マウスおよびヒトにおける1型糖尿病の発症の主要な自己抗原としてインスリンを提案する.
- ケント et al. ケント et al. ヒトインスリン断片に対する非典型のT細胞反応を記述し,インスリンが果たすべき役割に異議を唱える可能性がある.
結論:
- インスリンが1型糖尿病の主な自己抗原であるという仮説は,観察された非典型のT細胞反応のためにさらなる調査を必要とします.
- T細胞活性化におけるインスリンとその断片の役割を明確にすることは,効果的な1型糖尿病の予防と治療戦略の開発に不可欠です.
関連する概念動画
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

